Tang Capital Reports 4.8 Million Atea Shares, A 6% Passive Stake, In SEC Filing
Kevin Tang's firm and its affiliated funds list shared voting power over all 4,814,700 shares, and say they hold them without seeking control.
Tang Capital Management and Kevin Tang reported owning 4,814,700 shares of Atea Pharmaceuticals, or 6% of its common stock, in a Schedule 13G passive ownership filing made Tuesday. The stake is split across three affiliated funds, and the filers certify it is not meant to influence control of the company.
What the filing says
The Schedule 13G names six reporting persons: Tang Capital Management, Kevin Tang and four affiliated entities. Tang Capital Management is the general partner of two of the funds. Tang is its manager and also chief executive of the other two entities.
Three funds hold the shares, according to the filing:
- Tang Capital Partners, LP: 2,488,519 shares, or 3.1% of the class.
- Tang Capital Partners International, LP: 1,665,077 shares, or 2.1%.
- Tang Capital Partners III, Inc.: 661,104 shares, or 0.8%.
Tang Capital Partners IV, Inc. is also a filer but reports 0 shares and a 0% position. The filing lists the firm and Tang at 4747 Executive Drive in San Diego. Partners III and IV are listed in Las Vegas, and the filing describes them as Nevada corporations indirectly wholly owned by Tang Capital Partners.
Voting power and the control certification
Every reporting person shows zero sole voting power. Shared voting power matches each holder's share count, so the firm and Tang show 4,814,700 shares.
The filers also signed a certification that the shares were not acquired and are not held "for the purpose of or with the effect of changing or influencing the control of the issuer." That language is what keeps the filing in the passive category.
Where the stock stood
Atea shares closed Tuesday at $5.07, down 1.17%, and were unchanged in Tuesday after-hours trading, an early indicative reading. That put the company's market value at $411 million (market data).
The filing gives the event date as October 6, 2026, and lists Atea's address as 225 Franklin Street, Boston.
